Asbestos-related cancers: the ‘Hidden Killer’ remains a global threat

References

• Linton A, Vardy J, Clarke S, et al. The ticking time-bomb of asbestos: its insidious role in the development of malignant mesothelioma. Crit Rev Oncol Hematol. 2012;84(2):200–212.
   PubMed Web of Science ®Google Scholar
• Peterson JT Jr., Greenberg SD, Buffler PA. Non-asbestos-related malignant mesothelioma. A review. Cancer. 1984;54(5):951–960.
   PubMed Web of Science ®Google Scholar
• Farioli A, Ottone M, Morganti AG, et al. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database. Cancer Med. 2016;5(5):950–959.
   PubMed Web of Science ®Google Scholar
• Guo Z, Carbone M, Zhang X, et al. Improving the accuracy of mesothelioma diagnosis in China. J Thorac Oncol. 2017;12(4):714–723.
   PubMed Web of Science ®Google Scholar
• Henderson DW, Reid G, Kao SC, et al. Challenges and controversies in the diagnosis of malignant mesothelioma: part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. J Clin Pathol. 2013;66(10):854–861.
   PubMed Web of Science ®Google Scholar
• Henderson DW, Reid G, Kao SC, et al. Challenges and controversies in the diagnosis of mesothelioma: part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. J Clin Pathol. 2013;66(10):847–853.
   PubMed Web of Science ®Google Scholar
• Park EK, Takahashi K, Hoshuyama T, et al. Global magnitude of reported and unreported mesothelioma. Environ Health Perspect. 2011;119(4):514–518.
   PubMed Web of Science ®Google Scholar
• Soeberg MJ, Luong MA, Tran VT, et al. Estimating the incidence of malignant mesothelioma in Vietnam: a pilot descriptive cancer registration study. Int J Occup Environ Health. 2016;22(2):167–172.
   PubMed Web of Science ®Google Scholar
• Henderson DW, Rodelsperger K, Woitowitz HJ, et al. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004. Pathology. 2004;36(6):517–550.
   PubMed Web of Science ®Google Scholar
• Tossavainen A. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23(4):311–316.
   PubMed Web of Science ®Google Scholar
• Klebe S, Leigh J, Henderson DW, et al. Asbestos, smoking and lung cancer: an update. Int J Environ Res Public Health. 2019;17:1.
   Web of Science ®Google Scholar
• Landrigan PJ, Collegium R. Comments on the 2014 helsinki consensus report on asbestos. Ann Glob Health. 2016;82(1):217–220.
   PubMed Web of Science ®Google Scholar
• van der Bij S, Koffijberg H, Lenters V, et al. Lung cancer risk at low cumulative asbestos exposure: meta-regression of the exposure-response relationship. Cancer Causes Control. 2013;24(1):1–12.
   PubMed Web of Science ®Google Scholar
• Ferrante D, Chellini E, Merler E, et al. Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure. Occup Environ Med. 2017;74(12):887–898.
   PubMed Web of Science ®Google Scholar
• Offermans NSM, Vermeulen R, Burdorf A, et al. Occupational asbestos exposure and risk of esophageal, gastric and colorectal cancer in the prospective Netherlands cohort study. Int J Cancer. 2014;135(8):1970–1977.
   PubMed Web of Science ®Google Scholar
• Luberto F, Ferrante D, Silvestri S, et al. Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy. Environ Health. 2019;18(1):71.
   PubMed Web of Science ®Google Scholar
• Awan KH, Hegde R, Cheever VJ, et al. Oral and pharyngeal cancer risk associated with occupational carcinogenic substances: systematic review. Head Neck. 2018;40(12):2724–2732.
   PubMed Web of Science ®Google Scholar
• Bounin A, Charbotel B, Fervers B, et al. Professional risk factors associated with the cancer of the ovary. Literature review. Bull Cancer. 2014;101(12):1089–1108.
   PubMed Web of Science ®Google Scholar
• Reid A, de Klerk N, Musk AW. Does exposure to asbestos cause ovarian cancer? A systematic literature review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1287–1295.
   PubMed Web of Science ®Google Scholar
• Moline J, Bevilacqua K, Alexandri M, et al. Mesothelioma associated with the use of cosmetic talc. J Occup Environ Med. 2020;62(1):11–17.
   PubMed Web of Science ®Google Scholar
• Fitzgerald S, Harty E, Joshi TK, et al. Asbestos in commercial indian talc. Am J Ind Med. 2019;62(5):385–392.
   PubMed Web of Science ®Google Scholar
• Arsenic, Metals, Fibres and Dusts, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No.100C, IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Lyon (FR): International Agency for Research on Cancer; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304375/
   Google Scholar
• International Chrysotile Association. [cited 2020 Mar 20]. Available from: https://chrysotileassociation.com/
   Google Scholar
• Uralasbest. Available from: www.uralasbest.ru
   Google Scholar
• Chrysotile Information Center. Available from: http://www.chrysotile-asia.com/
   Google Scholar
• Fibre Cement Products Manufacturers Association. Available from: https://fcpma.in/
   Google Scholar
• Chrysotile Vietnam. Available from: https://chrysotile.vn.
   Google Scholar
• Holmes D. IARC in the dock over ties with asbestos industry. Lancet. 2013;381(9864):359–361.
   PubMed Web of Science ®Google Scholar
• McCulloch J. Saving the asbestos industry, 1960 to 2006. 433021. 2006;121(5):609–614.
   Google Scholar
• Baur X, Soskolne CL, Lemen RA, et al. How conflicted authors undermine the World Health Organization (WHO) campaign to stop all use of asbestos: spotlight on studies showing that chrysotile is carcinogenic and facilitates other non-cancer asbestos-related diseases. Int J Occup Environ Health. 2015;21(2):176–179.
   PubMed Web of Science ®Google Scholar
• Michaels D. Doubt is their product: how industry’s assault on science threatens your health. New York (NY): Oxford University Press; 2008.
   Google Scholar
• Hazards 144. 2018. Available from: http://www.hazards.org/haz144/index.htm
   Google Scholar
• Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008;38(Suppl 1):49–73.
   PubMed Web of Science ®Google Scholar
• Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(Suppl 1):1–47.
   PubMed Web of Science ®Google Scholar
• McDonald JC, McDonald AD, Hughes JM. Chrysotile, tremolite and fibrogenicity. Ann Occup Hyg. 1999;43(7):439–442.
   PubMedGoogle Scholar
• McDonald JC, McDonald AD. Chrysotile, tremolite and carcinogenicity. Ann Occup Hyg. 1997;41(6):699–705.
   PubMed Web of Science ®Google Scholar
• Bernstein D, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure. Inhal Toxicol. 2005;17(1):1–14.
   PubMed Web of Science ®Google Scholar
• Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 1996;86(2):179–186.
   PubMed Web of Science ®Google Scholar
• Wang X, Courtice MN, Lin S. Mortality in chrysotile asbestos workers in China. Curr Opin Pulm Med. 2013;19(2):169–173.
   PubMed Web of Science ®Google Scholar
• Wang X, Yano E, Qiu H, et al. A 37-year observation of mortality in Chinese chrysotile asbestos workers. Thorax. 2012;67(2):106–110.
   PubMed Web of Science ®Google Scholar
• Stayner L, Smith R, Bailer J, et al. Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. Occup Environ Med. 1997;54(9):646–652.
   PubMed Web of Science ®Google Scholar
• Dodson RF, Atkinson MA, Levin JL. Asbestos fiber length as related to potential pathogenicity: a critical review. Am J Ind Med. 2003;44(3):291–297.
   PubMed Web of Science ®Google Scholar
• Feder IS, Tischoff I, Theile A, et al. The asbestos fibre burden in human lungs: new insights into the chrysotile debate. Eur Respir J. 2017;49:6.
   Web of Science ®Google Scholar
• Joint Policy Committee of Epidemiology Societies. Position statement on asbestos; 2012. Available from: https://epidemiologyinpolicy.org/documents/01.JPC-SE-Position_Statement_on_Asbestos-June_4_2012-Summary_and_Appendix_A_English.pdf
   Google Scholar
• Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health. 2013;34:205–216.
   PubMed Web of Science ®Google Scholar
• Hadley B, Rennell T. Asbestos - the Future Risk. 1st ed. London, UK: Iskaboo Publishing Ltd; 2013 March 1; p. 157.
   Google Scholar
• Talcott JA, Thurber WA, Kantor AF, et al. Asbestos-associated diseases in a cohort of cigarette-filter workers. N Engl J Med. 1989;321(18):1220–1223.
   PubMed Web of Science ®Google Scholar
• Dodson RF, Hammar SP. Pleural mesothelioma in a woman whose documented past exposure to asbestos was from smoking asbestos-containing filtered cigarettes: the comparative value of analytical transmission electron microscopic analysis of lung and lymph-node tissue. Inhal Toxicol. 2006;18(9):679–684.
   PubMed Web of Science ®Google Scholar
• Frank AL, Joshi TK. The global spread of asbestos. Ann Glob Health. 2014;80(4):257–262.
   PubMed Web of Science ®Google Scholar
• Lemen RA, Dement JM, Wagoner JK. Epidemiology of asbestos-related diseases. Environ Health Perspect. 1980;34(Feb):1–11.
   PubMed Web of Science ®Google Scholar
• Ramazzini C. Call for an international ban on asbestos. J Occup Environ Med. 1999;41(10):830–832.
   PubMed Web of Science ®Google Scholar
• Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369(9564):844–849.
   PubMed Web of Science ®Google Scholar
• Ramazzini C. Asbestos is still with us: repeat call for a universal ban. J Occup Environ Med. 2010;52(5):469–472.
   PubMed Web of Science ®Google Scholar
• Ferrante D, Mirabelli D, Silvestri S, et al. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: a cohort study. Am J Ind Med. 2020;63(2):135–145.
   PubMed Web of Science ®Google Scholar
• Westerholm P, Remaeus B, Svartengren M. The Tale of Asbestos in Sweden 1972–1986-The Pathway to a Near-Total Ban. Int J Environ Res Public Health. 2017;14:11.
   Web of Science ®Google Scholar
• Gemba K, Fujimoto N, Kato K, et al. National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci. 2012;103(3):483–490.
   PubMed Web of Science ®Google Scholar
• Yoon Y-R, Kwak KM, Choi Y, et al. The asbestos ban in Korea from a grassroots perspective: why did it occur? Int J Environ Res Public Health. 2018;15(2):198.
   Web of Science ®Google Scholar
• Furuya S, Takahashi K. Experience of Japan in achieving a total ban on asbestos. Int J Environ Res Public Health. 2017;14:10.
   Web of Science ®Google Scholar
• Vincenten J, George F, Martuzzi M, et al. Barriers and facilitators to the elimination of asbestos related diseases-stakeholders’ perspectives. Int J Environ Res Public Health. 2017;14(10):1269.
   Web of Science ®Google Scholar
• Collegium R. The 18th Collegium Ramazzini statement: the global health dimensions of asbestos and asbestos-related diseases. Scand J Work Environ Health. 2016;42(1):86–90.
   PubMed Web of Science ®Google Scholar
• Ruff K. UN scientific agency collaborating with scientists involved in sabotaging UN rotterdam convention. Int J Occup Environ Health. 2013;19(3):160–162.
   PubMed Web of Science ®Google Scholar
• Kazan-Allen L. The asbestos war. Int J Occup Environ Health. 2003;9(3):173–193.
   PubMed Web of Science ®Google Scholar
• Ruff K. How Canada changed from exporting asbestos to banning asbestos: the challenges that had to be overcome. Int J Environ Res Public Health. 2017;14:10.
   Web of Science ®Google Scholar
• Kazan-Allen L. The debate on banning asbestos. CMAJ. 2001;165(9): 1189. author reply 91-3.
   PubMedGoogle Scholar
• Kazan-Allen L. Ban asbestos phenomenon: the winds of change. New Solut. 2011;21(4):629–636.
   PubMedGoogle Scholar
• Leong SL, Zainudin R, Kazan-Allen L, et al. Asbestos in Asia. Respirology. 2015;20(4):548–555.
   PubMed Web of Science ®Google Scholar
• Lemen RA, Landrigan PJ. Toward an asbestos ban in the United States. Int J Environ Res Public Health. 2017;14:11.
   Web of Science ®Google Scholar
• Noonan CW. Environmental asbestos exposure and risk of mesothelioma. Ann Transl Med. 2017;5(11):234.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Mesothelioma in Australia 2018. Australia; 2019. Available from: https://www.aihw.gov.au/reports/can/130/mesothelioma-in-australia-2018/contents/table-of-contents
   Google Scholar
• Soeberg MJ, Leigh J, van Zandwijk N. Malignant mesothelioma in Australia 2015: current incidence and asbestos exposure trends. J Toxicol Environ Health B Crit Rev. 2016;19(5–6):173–189.
   PubMed Web of Science ®Google Scholar
• Ferrante D, Mirabelli D, Tunesi S, et al. Pleural mesothelioma and asbestos exposure: a case-control study with quantitative risk assessment. Occup Environ Med. 2016;73(3):147–153.
   PubMed Web of Science ®Google Scholar
• Consonni D, De Matteis S, Dallari B, et al. Impact of an asbestos cement factory on mesothelioma incidence in a community in Italy. Environ Res. 2019;108968. DOI:10.1016/j.envres.2019.108968
   PubMed Web of Science ®Google Scholar
• Sinninghe Damsté HEJ, Siesling S, Burdorf A. Environmental exposure to asbestos in the area around Goor has been established as the cause of pleural mesothelioma in women. Ned Tijdschr Geneeskd. 2007;151(44):2453–2459.
   PubMedGoogle Scholar
• Dalsgaard SB, Würtz ET, Hansen J, et al. Environmental asbestos exposure in childhood and risk of mesothelioma later in life: a long-term follow-up register-based cohort study. Occup Environ Med. 2019;76(6):407–413.
   PubMed Web of Science ®Google Scholar
• Korda RJ, Clements MS, Armstrong BK, et al., Risk of cancer associated with residential exposure to asbestos insulation: a whole-population cohort study. Lancet Public Health. 2017;2(11):e522–e8.
   PubMed Web of Science ®Google Scholar
• Nielsen LS, Bælum J, Rasmussen J, et al. Occupational asbestos exposure and lung cancer–a systematic review of the literature. Arch Environ Occup Health. 2014;69(4):191–206.
   PubMed Web of Science ®Google Scholar
• Olsson AC, Vermeulen R, Schüz J, et al. Exposure-response analyses of asbestos and lung cancer subtypes in a pooled analysis of case-control studies. Epidemiology. 2017;28(2):288–299.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403.
   PubMed Web of Science ®Google Scholar
• van Zandwijk N, Reid G. Asbestos and the pathophysiology of mesothelioma. In: Ceresoli G, Bombardieri E, D’Incalci M, editors. Mesothelioma. Cham: Springer; 2019;19–33.
   Google Scholar
• Cheung M, Testa JR. BAP1, a tumor suppressor gene driving malignant mesothelioma. Transl Lung Cancer Res. 2017;6(3):270–278.
   PubMed Web of Science ®Google Scholar
• Ohar JA, Cheung M, Talarchek J, et al. Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer. Cancer Res. 2016;76(2):206–215.
   PubMed Web of Science ®Google Scholar
• Ascoli V, Cozzi I, Vatrano S, et al. Mesothelioma families without inheritance of a BAP1 predisposing mutation. Cancer Genet. 2016;209(9):381–387.
   PubMed Web of Science ®Google Scholar
• Betti M, Aspesi A, Sculco M, et al. Genetic predisposition for malignant mesothelioma: A concise review. Mutat Res. 2019;781:1–10.
   PubMed Web of Science ®Google Scholar
• Malhotra J, Malvezzi M, Negri E, et al. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889–902.
   PubMed Web of Science ®Google Scholar
• Yano E, Wang X, Wang M, et al. Lung cancer mortality from exposure to chrysotile asbestos and smoking: a case-control study within a cohort in China. Occup Environ Med. 2010;67(12):867–871.
   PubMed Web of Science ®Google Scholar
• Kettunen E, Hernandez-Vargas H, Cros M-P, et al. Asbestos-associated genome-wide DNA methylation changes in lung cancer. Int J Cancer. 2017;141(10):2014–2029.
   PubMed Web of Science ®Google Scholar
• Egilman D, Bird T, Lee C. Dust diseases and the legacy of corporate manipulation of science and law. Int J Occup Environ Health. 2014;20(2):115–125.
   PubMed Web of Science ®Google Scholar
• Castleman B. Criminality and asbestos in industry. New Solut. 2017;26(4):557–580.
   PubMed Web of Science ®Google Scholar
• Jadhav AV, Gawde NC. Current asbestos exposure and future need for palliative care in India. Indian J Palliat Care. 2019;25(4):587–591.
   PubMed Web of Science ®Google Scholar
• Singh R, Cherrie J, Rao B, et al. Assessment of the future mesothelioma disease burden from past exposure to asbestos in ship recycling yards in India. Int J Hyg Environ Health. 2020;225:113478;In print.
   PubMed Web of Science ®Google Scholar
• Gilmore AB, Fooks G, Drope J, et al. Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet. 2015;385(9972):1029–1043.
   PubMed Web of Science ®Google Scholar
• Fan X, McLaughlin C, Robinson C, et al. Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma. FASEB Bioadv. 2019;1(9):550–560.
   PubMedGoogle Scholar
• Reid G, Johnson T, van Zandwijk N. Manipulating microRNAs for the treatment of malignant pleural mesothelioma: past, present and future. Front Oncol. 2020;10. Available from: https://www.frontiersin.org/articles/10.3389/fonc.2020.00105/full
   PubMed Web of Science ®Google Scholar